Our History

From vision to a CE-certified solution — the story behind Axomera®.

Milestones

• 2008 — Founded: Columbus Health Products GmbH is founded with the goal of bringing bioelectric therapy into modern medical practice.
• 2019 — First prototypes: Development of the first device prototypes in close collaboration with orthopaedists and sports scientists.
• 2020 — Clinical studies: Start of clinical validation studies at Ruhr University Bochum and partner clinics.
• 2021 — CE approval: Axomera® receives CE approval as a Class IIa medical device under MDR 2017/745.
• 2022 — Market launch: Launch in Germany, Austria and Switzerland, with 150 practices in the first wave.
• 2023 — Clinical adoption grows: Growing clinical adoption in around 150 practices, including collaborations with BG and Helios clinics.
• 2024 — EU expansion: Expansion into additional EU countries and a new app platform with digital treatment protocols.
• 2025 — Axomera 2.0: A new device generation with an expanded protocol set and AI-assisted treatment recommendations.